Evaluation of trypanocidal and antioxidant activities of a selected series of 3-amidocoumarins
Author
dc.contributor.author
Moncada-Basualto, Mauricio
Author
dc.contributor.author
Lapier, Michel
Author
dc.contributor.author
Maya Arango, Juan
Author
dc.contributor.author
Matsuhiro, Betty
Author
dc.contributor.author
Olea Azar, Claudio
Author
dc.contributor.author
Delogu, Giovanna
Author
dc.contributor.author
Uriarte, Eugenio
Author
dc.contributor.author
Santana, Lourdes
Author
dc.contributor.author
João Matos, María
Admission date
dc.date.accessioned
2018-11-20T18:43:32Z
Available date
dc.date.available
2018-11-20T18:43:32Z
Publication date
dc.date.issued
2018
Cita de ítem
dc.identifier.citation
Medicinal Chemistry, 2018, Vol. 14(6), No. 00
es_ES
Identifier
dc.identifier.issn
1573-4064
Identifier
dc.identifier.other
10.2174/1573406414666180419113437
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/152738
Abstract
dc.description.abstract
Background: Neglected diseases are becoming more prevalent due to globalization. This has inspired active research in the development of new drugs for the treatment of parasitic diseases such as Chagas disease. Objectives: With the aim of finding new trypanocidal agents, we report the in vitro evaluation of a new series of 3-amidocoumarins with or without hydroxyl substituents at position 4 of the coumarin ring. Methods: Electrochemical and biological assays were performed in order to assess the antioxidant and trypanocidal potential of these compounds and to better understand the mechanisms involved in their activity. Results: Most of the studied compounds showed high trypanocidal activity against both epimastigote and trypomastigote forms, with IC50 values in the low micromolar range. Some of them have greater activity and selectivity than the reference compound, nifurtimox. Conclusion: Compound 2 is the most active of this series, being also non-cytotoxic against murine RAW 264.7 macrophages. Electrochemical and radical scavenging experiments were carried out, providing new information about the profile of the best derivatives, and the potential therapeutic application of the new 3-amidocoumarins.
es_ES
Patrocinador
dc.description.sponsorship
The authors thank PhD fellowship from CONICYT, MMB grant for operational expenses (No 21150192), ML Post-PhD/FONDECYT No 3160022, JDM FONDECYT No 1130189, COA FONDECYT 1150175 and Postdoctoral fellowship from Xunta da Galicia (ED481B 2014/086-0).